Medicine
Volume 36, Issue 7 , Pages 369-376, July 2008

Drug development and regulation

Duncan Richards MA MRCP works for GlaxoSmithKline Research and Development in Cardiovascular Clinical Development. He trained in clinical pharmacology in Oxford, UK. His research interests include the application of surrogate markers during drug development. Competing interests: Dr Richards is an employee of GlaxoSmithKline

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1357-3039(08)00116-3

doi:10.1016/j.mpmed.2008.04.007

Medicine
Volume 36, Issue 7 , Pages 369-376, July 2008

Article Tools

* Image Usage & Resolution